← Leaderboards
Ramon C. Sun
University Of Kentucky
$5,151,131
Attributed
$11,921,752
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.1M · FY2020–25$5M$3.8M$2.5M$1.3M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,921,752 · 5
By mechanism
R01$8,264,249 · 4
RM1$3,657,503 · 1
Top collaborators
- Matthew S. Gentry7 shared
- Peggi M Angel5 shared
- Sean Curtis Bendall5 shared
- Richard R Drake5 shared
- Stuart F Cogan2 shared
- Joseph J. Pancrazio2 shared
- Juan M. Pascual2 shared
- Craig R. Malloy1 shared
Most similar at University Of Kentucky
Same institution · by research overlap
- Olivier Thibault$6,789,321
- Michael A. Andrykowski$2,984,578
- Lyndsay E A Young$78,534
- James R Pauly$2,496,459
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposMolecularMetabolicMouse ModelMetabolismGlycogenGlucose MetabolismSamplingPolysaccharidesIn VivoStagingMethodologyReportingCognitionResolutionSpecimenStable IsotopeNeuronsBrain-Amp-Activated Protein KinaseGlucosePlayBiochemical5&Apos
Grant awards (19)
Deciphering the Glycan Code in Human Alzheimer's Disease Brain$736,681
R01 · FY2025 · AG · contact PI
Targeting Glycogen Metabolism in Ewing's Sarcoma: Diagnostic, Prognostic, and Therapeutic Applications$590,300
R01 · FY2025 · CA · contact PI
Aberrant Glycogen in Lung Adenocarcinoma Tumorigenesis$531,350
R01 · FY2025 · CA · contact PI
Brain glucose deficiency: mechanisms and modulation$1,875,099
RM1 · FY2024 · NS
Deciphering the Glycan Code in Human Alzheimer's Disease Brain$756,289
R01 · FY2024 · AG · contact PI
Targeting Glycogen Metabolism in Ewing's Sarcoma: Diagnostic, Prognostic, and Therapeutic Applications$600,688
R01 · FY2024 · CA · contact PI
Aberrant Glycogen in Lung Adenocarcinoma Tumorigenesis$504,786
R01 · FY2024 · CA · contact PI
Aberrant Glycogen Modulates Cerebral Glucose Metabolism in Aging and Alzheimer's Disease$381,250
R01 · FY2024 · AG · contact PI
Brain glucose deficiency: mechanisms and modulation$1,782,404
RM1 · FY2023 · NS
Deciphering the Glycan Code in Human Alzheimer's Disease Brain$760,730
R01 · FY2023 · AG · contact PI
Aberrant Glycogen in Lung Adenocarcinoma Tumorigenesis$533,624
R01 · FY2023 · CA · contact PI
Aberrant Glycogen Modulates Cerebral Glucose Metabolism in Aging and Alzheimer's Disease$381,250
R01 · FY2023 · AG · contact PI
Deciphering the Glycan Code in Human Alzheimer's Disease Brain$791,294
R01 · FY2022 · AG · contact PI
Aberrant Glycogen in Lung Adenocarcinoma Tumorigenesis$496,040
R01 · FY2022 · CA · contact PI
Aberrant Glycogen Modulates Cerebral Glucose Metabolism in Aging and Alzheimer's Disease$382,500
R01 · FY2022 · AG · contact PI
Aberrant Glycogen in Lung Adenocarcinoma Tumorigenesis$52,466
R01 · FY2022 · CA · contact PI
Deciphering the Glycan Code in Human Alzheimerâs Disease Brain$1
R01 · FY2022 · AG · contact PI
Aberrant Glycogen Modulates Cerebral Glucose Metabolism in Aging and Alzheimer's Disease$382,500
R01 · FY2021 · AG · contact PI
Aberrant Glycogen Modulates Cerebral Glucose Metabolism in Aging and Alzheimer's Disease$382,500
R01 · FY2020 · AG · contact PI